Reading, United Kingdom

Kate Budds

This inventor holds 6 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignee: The Gillette Company. Active years: 2020-2025.

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kate Budds

Introduction

Kate Budds is a prominent inventor based in Reading, GB. She has made significant strides in the field of digital imaging, particularly in analyzing skin conditions. With a total of six patents to her name, her work has garnered attention for its innovative approach to skincare technology.

Latest Patents

Among her latest patents, Budds has developed digital imaging systems and methods for analyzing pixel data of a user's skin area to determine skin hyperpigmentation. This technology utilizes a model trained with pixel data from various individuals to output skin hyperpigmentation values across a defined scale. Additionally, she has created similar systems for assessing skin dryness, which also rely on aggregated training images to provide user-specific recommendations based on the analysis of pixel data.

Career Highlights

Budds is currently employed at The Gillette Company, where she continues to push the boundaries of skincare technology. Her innovative contributions have positioned her as a key figure in the development of digital imaging solutions for personal care.

Collaborations

Some of her notable coworkers include Leigh Knight and Robyn Dolbear, who have collaborated with her on various projects within the company.

Conclusion

Kate Budds exemplifies the spirit of innovation in the field of digital imaging and skincare technology. Her patents reflect a commitment to improving user experiences through advanced analysis and recommendations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…